Bluejay Diagnostics (BJDX) Long-Term Deferred Tax (2020 - 2022)

Bluejay Diagnostics (BJDX) has 3 years of Long-Term Deferred Tax data on file, last reported at $2.7 million in Q4 2022.

• For the quarter ending Q4 2022, Long-Term Deferred Tax rose 200.0% year-over-year to $2.7 million; the trailing twelve-month figure through Dec 2022 stood at $2.7 million (up 200.0% YoY), and the FY2022 full-year result was $2.7 million, up 200.0% from the prior year.
• Long-Term Deferred Tax grew to $2.7 million in Q4 2022, from $900000.0 in the prior quarter.
• In the past five years, Long-Term Deferred Tax ranged from a high of $2.7 million in Q4 2022 to a low of $900000.0 in Q4 2021.
• A 3-year average of $1.6 million and a median of $1.1 million in 2020 frame the typical range for Long-Term Deferred Tax.
• Across the five-year window, Long-Term Deferred Tax decreased 15.9% in 2021 and surged 200.0% in 2022, its largest moves.
• Tracing BJDX's Long-Term Deferred Tax over 3 years: stood at $1.1 million in 2020, then dropped by 15.9% to $900000.0 in 2021, then surged by 200.0% to $2.7 million in 2022.
• Business Quant data shows BJDX's Long-Term Deferred Tax at $2.7 million in Q4 2022, $900000.0 in Q4 2021, and $1.1 million in Q4 2020.